Skip to main content
. 2017 Jun 14;7:3471. doi: 10.1038/s41598-017-02992-7

Table 1.

Comparison of clinical characteristics between patients with or without neoadjuvant radiotherapy in the original dataset and in the propensity score matched dataset.

Clinical Characters Before Propensity Score Matching After Propensity Score Matching
Sn (%) Sn + PRT (%) SD Sn (%) Sn + PRT (%) SD
RACE
Withe 5304 (80.07) 4997 (80.90) −0.0208 3996 (80.18) 3997 (80.20) −0.0005
Black 596 (9.00) 504 (8.16) 0.0299 461 (9.25) 427 (8.57) 0.0239
Unknown 724 (10.93) 676 (10.94) −0.0004 527 (10.57) 560 (11.24) −0.0212
GENDER
Male 3576 (53.99) 3868 (62.62) −0.1758 2961 (59.41) 3026 (60.71) −0.0266
Female 3048 (46.01) 2309 (37.38) 2023 (40.59) 1958 (39.29)
AGE
< = 50 956 (14.43) 1555 (25.17) −0.2720 956 (19.18) 1027 (20.61) −0.0357
>50 5668 (85.57) 4622 (74.83) 4028 (80.82) 3957 (79.39)
TUMOR NUMBER
Single 6046 (91.27) 5757 (93.20) −0.0720 4588 (92.05) 4608 (92.46) −0.0150
Multiple 578 (8.73) 420 (6.80) 396 (7.95) 376 (7.54)
TUMOR SIZE
< = 5 cm 4250 (64.16) 4518 (73.14) −0.1945 3467 (69.56) 3465 (69.52) 0.0009
>5 cm 2374 (35.84) 1659 (26.86) 1517 (30.44) 1519 (30.48)
TNM STAGE
II 2903 (43.83) 2647 (42.85) 0.0196 2133 (42.80) 2131 (42.76) 0.0008
III 3721 (56.17) 3530 (57.15) 2851 (57.20) 2853 (57.24)
HISTOLOGICAL TYPE
Non-mucinous 6234 (94.11) 5686 (92.05) 0.0813 4658 (93.46) 4585 (91.99) 0.0564
Mucinous 353 (5.33) 449 (7.27) −0.0799 291 (5.84) 373 (7.48) −0.0660
SRCC 37 (0.56) 42 (0.68) −0.0155 35 (0.70) 26 (0.52) 0.0232
GRADE
Well 358 (5.40) 378 (6.12) −0.0307 291 (5.84) 340 (6.82) −0.0404
Moderately 5166 (77.99) 4878 (78.97) −0.0239 3917 (78.59) 3881 (77.87) 0.0175
Poorly 992 (14.98) 827 (13.39) 0.0455 703 (14.11) 686 (13.76) 0.0098
undifferentiated 108 (1.63) 94 (1.52) 0.0087 73 (1.46) 77 (1.54) −0.0066
LYMPH NODE
negative 91 (1.37) 310 (5.02) −0.2083 91 (1.83) 168 (3.37) −0.0972
< = 12 1224 (18.48) 2127 (34.43) −0.3678 1181 (23.70) 1360 (27.29) −0.0825
>12 5309 (80.15) 3740 (60.55) 0.4394 3712 (74.48) 3456 (69.34) 0.1145

Sn: surgery only; Sn + PRT: pre-radiation treatment + surgery; SD: standardized difference; SRCC: sing-ring cell carcinoma.